Economic Evaluation of Ready-to-Dilute Thiotepa (Tepylute®): Institutional Cost Offsets and Time Savings Compared to Lyophilized Thiotepa in a United States Hospital Pharmacy
… a hazardous drug by the United States (US) Centers for Disease Control … cell lung cancer in the United States. J Med Econ. 2018;21 … non-hodgkin lymphoma to a United States infusion facility. Clinicoecon Outcomes Res …



